Coping With The Crisis At Science Libraries: Three Scenarios

[Editor's note: Between 1986 and 1988, the median price of professional science journals increased 32 percent faster than the increase in the cost of publishing them, according to the Association of Research Libraries, an organization representing 119 of the largest North American research libraries. During the same period, journal expenditures increased by 43 percent, but the number of titles that libraries bought remained the same. This, ARL says, is because skyrocketing prices have forced m

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

[Editor's note: Between 1986 and 1988, the median price of professional science journals increased 32 percent faster than the increase in the cost of publishing them, according to the Association of Research Libraries, an organization representing 119 of the largest North American research libraries. During the same period, journal expenditures increased by 43 percent, but the number of titles that libraries bought remained the same.

This, ARL says, is because skyrocketing prices have forced many libraries to cancel subscriptions to old titles and declare moratoriums on acquiring new ones. Librarians call it the "serials crisis." Publishers call it the "library problem" (The Scientist, July 24, 1989, page 1).

Meanwhile, scientists who depend on these journals for their work are concerned that the disappearance of information from library shelves is thwarting important research. And, by any label, all parties seem to agree that the steady increase in journal prices has reached ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies